Team:ATOMS-Turkiye/Results1
From 2014.igem.org
Sayinorhan (Talk | contribs) |
Sayinorhan (Talk | contribs) |
||
Line 51: | Line 51: | ||
<li>For Aprotinin, GPx, SOD and tPA; | <li>For Aprotinin, GPx, SOD and tPA; | ||
</li> | </li> | ||
- | <img src="https://static.igem.org/mediawiki/2014/thumb/f/f3/ATOMS_results_1.png/800px-ATOMS_results_1.png"> | + | <img src="https://static.igem.org/mediawiki/2014/thumb/f/f3/ATOMS_results_1.png/800px-ATOMS_results_1.png" style="margin-left:70px"> |
<li>For ODD; | <li>For ODD; | ||
</li> | </li> | ||
- | <img src="https://static.igem.org/mediawiki/2014/thumb/3/3f/ATOMS_results_2.png/800px-ATOMS_results_2.png"> | + | <img src="https://static.igem.org/mediawiki/2014/thumb/3/3f/ATOMS_results_2.png/800px-ATOMS_results_2.png" style="margin-left:70px"> |
<li>For HRE and KB regulator genes; | <li>For HRE and KB regulator genes; | ||
</li> | </li> | ||
- | <img src="https://static.igem.org/mediawiki/2014/thumb/6/60/ATOMS_results_3.png/800px-ATOMS_results_3.png"> | + | <img src="https://static.igem.org/mediawiki/2014/thumb/6/60/ATOMS_results_3.png/800px-ATOMS_results_3.png" style="margin-left:70px"> |
- | <img src="https://static.igem.org/mediawiki/2014/thumb/6/63/ATOMS_results_4.png/800px-ATOMS_results_4.png"> | + | <img src="https://static.igem.org/mediawiki/2014/thumb/6/63/ATOMS_results_4.png/800px-ATOMS_results_4.png" style="margin-left:70px"> |
<li>This system includes few understructured elements called TetR-VP16 complex and two different plasmids, pTet-off and pTRE vectors. In the pTet-off plasmid, PCMV constitutive promoter codes for TetR-VP16 protein complex in medium strength which can bind to its responding element present in the second plasmid, pTRE. Tetracycline respond element (TetRE) is a protein binding domain which enables the binding of TetR component of the protein complex. Whereas, VP16 component works as a transcription activator for the weak constitutive promoter (PminiCMV) which exists in the pTRE vector. TetR-VP16 protein complex can activate this weak promoter in pTRE vector. | <li>This system includes few understructured elements called TetR-VP16 complex and two different plasmids, pTet-off and pTRE vectors. In the pTet-off plasmid, PCMV constitutive promoter codes for TetR-VP16 protein complex in medium strength which can bind to its responding element present in the second plasmid, pTRE. Tetracycline respond element (TetRE) is a protein binding domain which enables the binding of TetR component of the protein complex. Whereas, VP16 component works as a transcription activator for the weak constitutive promoter (PminiCMV) which exists in the pTRE vector. TetR-VP16 protein complex can activate this weak promoter in pTRE vector. | ||
</li> | </li> |
Revision as of 23:56, 17 October 2014
Sensing
- We aimed to demonstrate its functionality by inserting it into pTRE-Luc vector.
- We expect that HRE, as an enhancer, would activate the promoter existing on the downstream region of it, depending on the level of HIF1alfa in the media which is increased in hypoxic conditions.
Expected To understand which colony our gene is inserted among the colonies that we transformated HRE-pTRE-luciferase vector, we expected the picture above when we perform PCR when we use pTRE-Luc forward and MCS reverse primers. |
Experimented From the samples we perform colony PCR by using pTRE-Luc forward and MCS reverse primers, we obtained a band in 428 bp line. This image proves that our HRE sequnce is inserted into the vector, successfully. |
Luciferase Assay
We are currently testing the chemotactic response of our chassis to physiologically relevant malate concentration levels below 10-6 M. To obtain these results we have reassessed the data collection method based on flow cytometry, because this should speed up the process of data collection and accuracy. To distinguish our bacteria from the background particles we have cotransformed our chassis with a low copy plasmid pTAC1 containing GFP, so our cells can be uniquely visualised using flow cytometer even if their size is similar to the size of backround particles. Hopefully this new strategy will produce results for presentation in Boston.
As the amount of IAA needed for enhancing plant growth depends on whether our bacteria are producing the compound outside or inside the plants, we attempted to replicate these findings.
Therapy
[1] National Institute of Health. (no date) Model Organisms for Biomedical Research. [Online]. Available from: http://www.nih.gov/science/models/arabidopsis/index.html [Accessed 21st September 2011].
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Vestibulum tortor quam, feugiat en ullamcorper pharetra. Vestibulum erat wisi, condimentum sed, commodo vitae, ornare sit amet, wisi. Aenean fermentum, elit eget tincidunt condimentum, eros ipsum rutrum orci, sagittis tempus lacus enim ac dui. Donec non enim in turpis pulvinar facilisis. Ut felis. Praesent dapibus, neque id cu
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Vestibulum tortor quam, feugiat en ullamcorper pharetra. Vestibulum erat wisi, condimentum sed, commodo vitae, ornare sit amet, wisi. Aenean fermentum, elit eget tincidunt condimentum, eros ipsum rutrum orci, sagittis tempus lacus enim ac dui. Donec non enim in turpis pulvinar facilisis. Ut felis. Praesent dapibus, neque id cu
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Vestibulum tortor quam, feugiat en ullamcorper pharetra. Vestibulum erat wisi, condimentum sed, commodo vitae, ornare sit amet, wisi. Aenean fermentum, elit eget tincidunt condimentum, eros ipsum rutrum orci, sagittis tempus lacus enim ac dui. Donec non enim in turpis pulvinar facilisis. Ut felis. Praesent dapibus, neque id cu